Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 243INDUSTRY 76NIH 28NETWORK 6OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Myeloid 2Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 63Neoplasms 40Colorectal Neoplasms 30Uterine Cervical Neoplasms 29Carcinoma, Hepatocellular 23Stomach Neoplasms 19Prostatic Neoplasms 19Carcinoma, Non-Small-Cell Lung 19Ovarian Neoplasms 16Lung Neoplasms 14Esophageal Neoplasms 13Multiple Myeloma 12Pancreatic Neoplasms 11Endometrial Neoplasms 10Urinary Bladder Neoplasms 9Motor Activity 9Colonic Neoplasms 9Recurrence 8Rectal Neoplasms 8Lymphoma, Follicular 8Melanoma 7Lymphoma 7Liver Neoplasms 7Carcinoma, Ovarian Epithelial 7Triple Negative Breast Neoplasms 6Sleep Initiation and Maintenance Disorders 6Sarcopenia 6Neuroendocrine Tumors 6Leukemia 6Hematologic Neoplasms 6

Interventions

defactinib 1decitabine and cedazuridine drug combination 1cedazuridine 1Decitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Myelodysplastic Syndromes × 1 year × Clear all
NCT05636514 2026-03-18

CELESTIAL-MDS

Clinical Hub for Interventional Research (CHOIR)

Phase 1 Recruiting
12 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT06944119 2025-07-28

Assesment of the Immune Response to RSV Vaccine in Patients With Myeloma, Lymphoma and Hematological Leukemia

Tel-Aviv Sourasky Medical Center

Active not recruiting
250 enrolled
LymphoidMyeloidPlasma cell

Lymphoma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡